⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Torrent Pharmaceuticals Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Torrent Pharmaceuticals Ltd.
↗Ahmedabad, India
Torrent Pharmaceuticals is a flagship company of the Torrent Group and a prominent Indian multinational pharmaceutical firm headquartered in Ahmedabad, Gujarat. It is a leader in therapeutic segments including cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), and women's healthcare, with a significant presence in diabetology, pain management, oncology, and anti-infectives.
The company operates globally across more than 50 countries, with strong market positions in India, Brazil, and Germany. It is known for its focus on chronic and sub-chronic therapies, differentiated generics, and biosimilars, supported by advanced R&D centers and world-class manufacturing facilities.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10001-50000
Revenue:$1.4B
Founded:1959
Ownership:public
Status:operating
STOCK
Exchange:BSE|NSE
Ticker:TORNTPHARM
Market Cap:$XXB
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biosimilar
Active Trials:158
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Torrent Group
Subsidiaries:19 subsidiaries and 1 associate company (as of FY25)
Key Partnerships:Novo Nordisk (manufacturing/supply of insulin for India)
COMPETITION
Position:Leader
Competitors:Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Lupin
LEADERSHIP
Key Executives:
Samir Mehta - Chairman
Aman Mehta - Managing Director
Scientific Founders:U. N. Mehta
LINKS
Website:torrent.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Torrent Pharmaceuticals Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.